Results 241 to 250 of about 412,112 (380)
Quality of life in heart failure. The heart of the matter. A scientific statement of the Heart Failure Association and the European Association of Preventive Cardiology of the European Society of Cardiology
European Journal of Heart Failure, EarlyView.For most patients with chronic, progressive illnesses, maintaining good quality of life (QoL), with preserved functional capacity, is just as crucial as prolonging survival. Patients with heart failure (HF) experience much worse QoL and effort intolerance than both the general population and people with other chronic conditions, since they present a ...Maurizio Volterrani, Geza Halasz, Stamatis Adamopoulos, Pier Giuseppe Agostoni, Javed Butler, Andrew J.S. Coats, Alan Cohen‐Solal, Wolfram Doehner, Gerasimos Filippatos, Ewa Jankowska, Carolyn S.P. Lam, Ekaterini Lambrinou, Lars H. Lund, Giuseppe Rosano, Marco Metra, Stefania Paolillo, Pasquale Perrone Filardi, Amina Rakisheva, Gianluigi Savarese, Petar Seferovic, Carlo Gabriele Tocchetti, Massimo Piepoli +21 morewiley +1 more sourceThe Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age.
The Journal of Heart and Lung Transplantation, 2013 R. Yusen, J. Christie, L. Edwards, A. Kucheryavaya, C. Benden, A. Dipchand, F. Dobbels, R. Kirk, L. Lund, A. Rahmel, J. Stehlik +10 moresemanticscholar +1 more sourceThe International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: 37th adult lung transplantation report - 2020; focus on deceased donor characteristics.
The Journal of Heart and Lung Transplantation, 2020 D. Chambers, A. Zuckermann, W. Cherikh, Michael O. Harhay, D. Hayes, E. Hsich, K. Khush, L. Potena, A. Sadavarte, T. Singh, J. Stehlik +10 moresemanticscholar +1 more sourceCurrent and novel biomarkers in cardiogenic shock
European Journal of Heart Failure, EarlyView.A summary of current and novel biomarkers and their potential stages of release in cardiogenic shock. The diagram illustrates the proposed release of the biomarkers during the different stages of cardiogenic shock: progression from cardiac dysfunction/stress, through to inflammation and end‐organ dysfunction.Victor Galusko, Florian A. Wenzl, Christophe Vandenbriele, Vasileios Panoulas, Thomas F. Lüscher, Diana A. Gorog +5 morewiley +1 more sourceInternational Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation
The Journal of Heart and Lung Transplantation, 2020 T. Martinu, A. Koutsokera, C. Benden, E. Cantu, Daniel Chambers, M. Cypel, Jeffrey Edelman, A. Emtiazjoo, Andrew J. Fisher, J. Greenland, Don Hayes, David Hwang, Brian C. Keller, E. Lease, M. Perch, Masaaki Sato, Jamie L. Todd, Stijn E. Verleden, Jan von der Thüsen, S. Weigt, Shaff Keshavjee, Tereza Angela Shaf S. Samuel Masaaki Cecilia David Wilson Martinu Koutsokera Keshavjee Weigt Sato Chaparro R, T. Martinu, A. Koutsokera, Shaff Keshavjee, S. Weigt, Masaaki Sato, C. Chaparro, D. Roe, F. D'Ovidio, G. Chaux, G. Snell, L. Godinas, M. Al-Aloul, S. Hays, Jamie L. Todd, M. Perch, Amy L. Rigby, Louis Clauden, M. Morrell, Puneet S Garcha, S. Raman, S. Jyothula, M. Trotter, E. Lease, Jeffrey Edelman, C. Kennedy, C. Hage, S. Aslam, S. Husain, Jan von der Thüsen, Andrew J. Fisher, K. Wassilew, R. Rampolla-Selles, S. Kapnadak, Umesh Goswami, J. Greenland, A. Emtiazjoo, A. Gregson, B. Vanaudenaerde, T. Gan, David Hwang, Brian C. Keller, Laura K Frye, M. Hannan, H. Seethamraju, R. Tomic, R. Bag, A. Mitchell, Stijn E. Verleden, Daniel Chambers, J. Mallea, M. Crespo, S. Bhorade, Cantu Edward, Cypel Marcelo, G. Dhillon, J. Christie, J. Luc, K. Wille, O. Akindipe, Omar Mohamedaly, C. Wigfield, Don Hayes, C. Benden, E. Melicoff-Portillo, M. Schecter, Shailendra Das, A. Orchanian‐Cheff, George Tomlinson +89 moresemanticscholar +1 more sourceSacubitril/valsartan versus valsartan initiation in patients naïve to renin–angiotensin system inhibitors: Insights from PARAGLIDE‐HF
European Journal of Heart Failure, EarlyView.Changes in N‐terminal pro‐B‐type natriuretic peptide and assessment of clinical endpoints according to prior exposure to renin–angiotensin system inhibitors in the Pre‐specified substudy of Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE‐HF).Nina Nouhravesh, Alexander H. Gunn, Derek Cyr, Adrian F. Hernandez, David A. Morrow, Eric J. Velazquez, Jonathan H. Ward, Samiha Sarwat, Kavita Sharma, Kristin M. Williamson, Randall C. Starling, Serge Lepage, Shelley Zieroth, Scott D. Solomon, Robert J. Mentz +14 morewiley +1 more source